MiRus
-
Spine
MiRus Receives Breakthrough Device Designation for Spine Implant
ATLANTA, July 31, 2024 /PRNewswire/ — MiRus has received Breakthrough Device Designation from the FDA for the EUROPA® Posterior Cervical System, based on it’s…
Read More » -
Spine
MiRus Announces FDA 510(k) Clearance for Molybdenum-Rhenium (MoRe®) Low Profile Anterior Cervical and Lateral Lumbar Plating Systems
ATLANTA, Oct. 18, 2023 /PRNewswire/ — MiRus® announced that it has received FDA 510(k) clearance of the CYGNUS™ MoRe® Anterior Cervical Plate…
Read More » -
Extremities
MiRus® Announces Launch of Molybdenum-Rhenium Low Profile ATLAS™ MoRe® Foot and Ankle Plating System
ATLANTA, Sept. 18, 2023 /PRNewswire/ — MiRus announces limited market release in the U.S. of its ATLAS™ MoRe® Foot and Ankle Plating System, the…
Read More » -
Regulatory
MiRus Receives FDA 510(K) Clearance For The Lowest Profile and Best-in-class Expandable Lumbar Interbody
ATLANTA, Aug. 31, 2021 /PRNewswire/ — MiRus LLC, the leading innovator in rhenium-based superalloy medical implants announced today that it has received…
Read More » -
Financial
MiRus Announces Appointment of Angela Coldwell as Chief Financial Officer
ATLANTA, Aug. 2, 2021 /PRNewswire/ — MiRus™ announced today that Angela Coldwell has joined the company’s Leadership Team as Chief Financial Officer effective July 6,…
Read More » -
Extremities
MiRus™ Raises $65 Million For Expansion of Rhenium-based Medical Devices
ATLANTA, July 27, 2021 /PRNewswire/ — MiRus LLC, a commercial stage life sciences company, has completed a highly oversubscribed funding round for growth…
Read More » -
Spine
MiRus Announces Mark S. Faucett as Vice President of Business Development
Mark S. Faucett- VP of Business Development ATLANTA, July 6, 2021 /PRNewswire/ — MiRus™ announced today that Mark Faucett has joined the company’s…
Read More » -
Spine
MiRus™ Launches MoRe® Promise- a Lifetime Limited Warranty for its Molybdenum-Rhenium Superalloy Rod
ATLANTA, Feb. 23, 2021 /PRNewswire/ — MiRus announced today that they will offer a LIFETIME LIMITED WARRANTY on its Molybdenum-Rhenium ( MoRe®) superalloy rod technology.…
Read More » -
Regulatory
MiRus™ Announces First Clinical Use of the MiRus™ 3DR™ Printed Lumbar Interbody Fusion System
ATLANTA, June 11, 2020 /PRNewswire/ — MiRus is pleased to announce that it received FDA 510(k) clearance for its 3DR™ (Randomized) Printed…
Read More » -
Spine
First Spine Surgeries Using The MoRe® Superalloy
ATLANTA, Aug. 30, 2019 /PRNewswire/ — MiRus announces successful spine surgeries at several centers across the country using the MoRe® superalloy. MiRus had…
Read More » -
Regulatory
MiRus Receives FDA Clearance for Lowest Profile Anterior Cervical Plate System
ATLANTA, July 26, 2019 /PRNewswire/ — MiRus is pleased to announce recent FDA 510(k) clearance of the CYGNUS™ Anterior Cervical Plate System, the…
Read More » -
Regulatory
First System for Dynamic Intra-operative Measurement of Segmental and Global Spine Alignment Receives FDA Clearance
ATLANTA, July 22, 2019 /PRNewswire/ — MiRus is pleased to announce FDA 510(k) clearance of the GALILEO™ Spine Alignment Monitoring System, a non-optical,…
Read More » -
Extremities
MiRus™ Acquires 50,000 SQFT Manufacturing Facility
ATLANTA, June 24, 2019 /PRNewswire/ — Following the 510(k) clearance by FDA in March 2019 of MoRe®, a proprietary molybdenum rhenium superalloy for medical implants,…
Read More » -
Regulatory
FDA Approves First Medical Implant with New Superalloy
ATLANTA, March 27, 2019 /PRNewswire/ — MiRus has received FDA 510(k) approval for the MoRe® based Europa™ Pedicle Screw System making it the…
Read More »